These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12660503

  • 1. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole.
    Jeng S, Chanchairujira T, Jusko W, Steiner R.
    Transplantation; 2003 Mar 27; 75(6):792-5. PubMed ID: 12660503
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ther Drug Monit; 2008 Jun 27; 30(3):282-91. PubMed ID: 18520599
    [Abstract] [Full Text] [Related]

  • 3. Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.
    Videla C, Vega J, Borja H.
    Transplant Proc; 2005 Apr 27; 37(3):1574-6. PubMed ID: 15866677
    [Abstract] [Full Text] [Related]

  • 4. Decision support tool to individualize cyclosporine dose in stable, long-term heart transplant recipients receiving metabolic inhibitors: overcoming limitations of cyclosporine C2 monitoring.
    Ray JE, Keogh AM, McLachlan AJ.
    J Heart Lung Transplant; 2006 Oct 27; 25(10):1223-9. PubMed ID: 17045935
    [Abstract] [Full Text] [Related]

  • 5. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 27; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 6. Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study.
    el-Dahshan KF, Bakr MA, Donia AF, Badr Ael-S, Sobh MA.
    Nephrol Dial Transplant; 2004 Jun 27; 19(6):1613-7. PubMed ID: 15034161
    [Abstract] [Full Text] [Related]

  • 7. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients.
    Hollander AA, van Rooij J, Lentjes GW, Arbouw F, van Bree JB, Schoemaker RC, van Es LA, van der Woude FJ, Cohen AF.
    Clin Pharmacol Ther; 1995 Mar 27; 57(3):318-24. PubMed ID: 7697949
    [Abstract] [Full Text] [Related]

  • 8. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    Jaksch P, Kocher A, Neuhauser P, Sarahrudi K, Seweryn J, Wisser W, Klepetko W.
    J Heart Lung Transplant; 2005 Aug 27; 24(8):1076-80. PubMed ID: 16102443
    [Abstract] [Full Text] [Related]

  • 9. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
    Patel CG, Harmon M, Gohh RY, Akhlaghi F.
    Ther Drug Monit; 2007 Feb 27; 29(1):87-95. PubMed ID: 17304155
    [Abstract] [Full Text] [Related]

  • 10. The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus.
    Akhlaghi F, Dostalek M, Falck P, Mendonza AE, Amundsen R, Gohh RY, Asberg A.
    Ther Drug Monit; 2012 Feb 27; 34(1):38-45. PubMed ID: 22210099
    [Abstract] [Full Text] [Related]

  • 11. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R, Böger J, Kuse E, Klempnauer J, Nashan B.
    Liver Transpl; 2004 May 27; 10(5):686-91. PubMed ID: 15108262
    [Abstract] [Full Text] [Related]

  • 12. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL.
    Transplantation; 2003 Jul 27; 76(2):370-5. PubMed ID: 12883195
    [Abstract] [Full Text] [Related]

  • 13. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F, Gonzalez L, Trull AK.
    J Heart Lung Transplant; 2005 Dec 27; 24(12):2120-8. PubMed ID: 16364860
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T, Zeier M, Schemmer P, Uhl W, Schoels M, Dengler T, Buechler M, Meuer S.
    Transplantation; 2004 Feb 15; 77(3):339-44. PubMed ID: 14966405
    [Abstract] [Full Text] [Related]

  • 15. Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients.
    Kuzuya T, Kobayashi T, Moriyama N, Nagasaka T, Yokoyama I, Uchida K, Nakao A, Nabeshima T.
    Transplantation; 2003 Sep 15; 76(5):865-8. PubMed ID: 14501869
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M, Crespo M, Millán O, Serón D, Torregrosa V, Jiménez O, Moreso F, Martorell J, Grinyo JM, Oppenheimer F.
    Transplant Proc; 2007 Sep 15; 39(7):2160-2. PubMed ID: 17889124
    [Abstract] [Full Text] [Related]

  • 17. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.
    Hesselink DA, van Dam T, Metselaar HJ, Balk AH, Mathôt RA, Smak Gregoor PJ, Weimar W, van Gelder T.
    Transpl Int; 2004 Oct 15; 17(9):495-504. PubMed ID: 15338117
    [Abstract] [Full Text] [Related]

  • 18. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ, Kubler PA, Lynch SV, Allen J, Butler M, Pillans PI.
    Ann Pharmacother; 2004 Feb 15; 38(2):205-8. PubMed ID: 14742751
    [Abstract] [Full Text] [Related]

  • 19. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients.
    Ost L.
    Transplantation; 1987 Oct 15; 44(4):533-5. PubMed ID: 3313841
    [Abstract] [Full Text] [Related]

  • 20. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K, Urano K, Matsuda H, Mizutani H, Iwamoto T, Okuda M.
    J Pharmacol Exp Ther; 2009 Jan 15; 328(1):249-55. PubMed ID: 18842703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.